ETFis Series Trust I - Virtus LifeSci Biotech Clinical Trials ETF
BBC
Get informed when a big investor buys or sells
+ FollowMarket Cap$2.27B
Close$
Share Statistics
| Market cap | $2.27 Billion |
|---|---|
| Enterprise Value | - |
| Dividend Yield | $0.66 (1.48%) |
| Earnings per Share | $- |
| Beta | 1.26 |
| Outstanding Shares | - |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | - |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
Insider Trades
Institutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 39.71%▲ 8.55% |
|---|---|
| Total Invested | $19.91M▲ 61.31% |
| Investors Holding | 21▲ 1.00% |
ESG Score
No data
About ETFis Series Trust I
CEO: George Aylward This exchange-traded fund (ETF) seeks to provide a high level of current income, with capital appreciation as a secondary goal. The fund is a series of the ETFIS Series Trust I.